Kurnool Institute Of Oncology Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.36 Cr
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.94 Cr
- Satisfied Charges ₹ 13.17 Cr
- Revenue Growth 21.51%
- Profit Growth 61.95%
- Ebitda 50.74%
- Net Worth 42.01%
- Total Assets 67.76%
About Kurnool Institute Of Oncology
Kurnool Institute Of Oncology Private Limited (KIOOPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 September 2014 and has a history of Ten years and four months. Its registered office is in Kurnool, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.36 Cr.
The company currently has active open charges totaling ₹24.94 Cr. The company has closed loans amounting to ₹13.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohan Chigurupati, Padmaja Chigurupati, and Venkata Yellampalli serve as directors at the Company.
Company Details
- Location
Kurnool, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U93030AP2014PTC095320
- Company No.
095320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Kurnool Institute Of Oncology?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohan Chigurupati | Director | 23-Jan-2017 | Current |
Padmaja Chigurupati | Director | 20-May-2016 | Current |
Venkata Yellampalli | Director | 20-May-2016 | Current |
Financial Performance of Kurnool Institute Of Oncology.
Kurnool Institute Of Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.51% increase. The company also saw a substantial improvement in profitability, with a 61.95% increase in profit. The company's net worth Soared by an impressive increase of 42.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kurnool Institute Of Oncology?
In 2023, Kurnool Institute Of Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹24.94 Cr
₹13.17 Cr
Charges Breakdown by Lending Institutions
- Others : 13.78 Cr
- Hdfc Bank Limited : 11.16 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Jan 2024 | Hdfc Bank Limited | ₹1.96 Cr | Open |
28 Nov 2022 | Others | ₹11.23 Cr | Open |
30 Jun 2022 | Others | ₹2.55 Cr | Open |
29 Oct 2018 | Hdfc Bank Limited | ₹9.20 Cr | Open |
30 Dec 2016 | Others | ₹7.40 M | Satisfied |
How Many Employees Work at Kurnool Institute Of Oncology?
Kurnool Institute Of Oncology has a workforce of 176 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kurnool Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kurnool Institute Of Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.